Bioavailability enhancement of repaglinide from transdermally applied nanostructured lipid carrier gel: Optimization, in vitro and in vivo studies

Repaglinide (RG) is an effective anti-diabetic drug (BCS class II) with limited oral bioavailability 

Saved in:
Bibliographic Details
Published in:Journal of drug delivery science and technology 2020-06, Vol.57, p.101731, Article 101731
Main Authors: Pandey, Sonia S., Patel, Mayuri A., Desai, Ditixa T., Patel, Hetal P., Gupta, Arti R., Joshi, Shrikant V., Shah, Dinesh O., Maulvi, Furqan A.
Format: Article
Language:English
Subjects:
Bioavailability
Box behnken design
Nanostructure lipid carrier
Repaglinide
Transdermal delivery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Repaglinide (RG) is an effective anti-diabetic drug (BCS class II) with limited oral bioavailability 
ISSN:1773-2247
DOI:10.1016/j.jddst.2020.101731